ACURX PHARMACEUTICALS INC (ACXP)
US00510M1045 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 5.76M | 7.47M | 9.11M | 12.96M | 3.18M | |||
| Receivables | 97.37K | 129.16K | N/A | N/A | N/A | |||
| Other Current Assets | 122.82K | 105.78K | 260.00K | 300.00K | 50.00K | |||
| Total Current Assets | 5.98M | 7.71M | 9.38M | 13.25M | 3.22M | |||
| Non-Current Assets | ||||||||
| Total Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL ASSETS | 5.98M | 7.71M | 9.38M | 13.25M | 3.22M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 20.00K | |||
| Accrued Expenses | 3.30M | 3.04M | 2.03M | 780.00K | 460.00K | |||
| Accounts Payable | 19.10K | 3.81K | 30.00K | 60.00K | 0.00 | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 3.32M | 3.04M | 2.06M | 840.00K | 470.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 50.00K | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 50.00K | |||
| TOTAL LIABILITIES | 3.32M | 3.04M | 2.06M | 840.00K | 520.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -64.54M | -53.22M | -38.64M | -26.55M | -13.80M | |||
| Additional Paid In Capital | 67.19M | 57.87M | 45.94M | 38.95M | N/A | |||
| Common Shares | 16.77K | 14.47K | 10.00K | 10.00K | 16.50M | |||
| Shares Outstanding | 16.77M | 14.47M | 11.63M | 10.22M | 9.54M | |||
| Tangible Book Value per Share | 0.16 | 0.32 | 0.63 | 1.21 | 0.28 | |||
| Total Shareholders' Equity | 2.66M | 4.67M | 7.32M | 12.41M | 2.70M | |||
| TOTAL LIABILITIES AND EQUITY | 5.98M | 7.71M | 9.38M | 13.25M | 3.22M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.02 | |||
| Current Ratio | 1.80 | 2.53 | 4.55 | 15.77 | 6.85 | |||
| Return On Assets (ROA) | -274.72% | -189.10% | -128.89% | -96.23% | -142.86% | |||
| Return On Equity (ROE) | -616.97% | -312.38% | -165.16% | -102.74% | -170.37% | |||
All data in USD , ROIC based on taxRate of 0.21